A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.
B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME). Their anti-tumor functions include recognizing tumor-associated antigens, ...
B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME). Their anti-tumor functions include recognizing tumor-associated antigens, ...
DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according to a speaker at the Congress of Clinical Rheumatology East ...
About five million people worldwide have systemic lupus erythematosus (SLE), an autoimmune disease that damages organs and tissues throughout the body, including skin, joints, kidneys, heart, and ...
MedPage Today on MSN
Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy
Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...
Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...
Just returned from ASN 2025 Kidney Week in Houston, Dr Pietro A. Canetta reports that there was major excitement surrounding new drug developments for glomerular diseases, especially immunoglobulin A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results